Stack Components.
Cat 1 / Cat 2
GH Axis Optimizer
Modified growth hormone-releasing hormone analog (CJC-1295) paired with a selective growth hormone secretagogue (ipamorelin). Stimulates natural, pulsatile GH release without disrupting other pituitary hormones.
In this stack: Serves as the foundation by elevating GH and downstream IGF-1. This supports protein synthesis, nitrogen retention, and lipolysis through the natural GH axis. The pulsatile release pattern preserves feedback sensitivity, avoiding the desensitization seen with continuous GH exposure.
Category 1
Targeted Lipolysis Agent
Modified fragment (amino acids 176-191) of the growth hormone molecule that retains lipolytic activity without growth-promoting or diabetogenic effects.
In this stack: Provides direct lipolytic signaling through a GH-receptor-independent mechanism. AOD-9604 stimulates lipolysis and inhibits lipogenesis in adipose tissue without the insulin resistance, fluid retention, or growth effects of full-length GH. This isolates the fat-loss component of GH action.
Category 1
Metabolic Amplifier
Mitochondrial-derived peptide that activates AMPK, the master metabolic sensor, enhancing glucose uptake, fatty acid oxidation, and metabolic flexibility.
In this stack: Adds a metabolic dimension by activating AMPK-driven energy expenditure. This increases the caloric deficit on the expenditure side rather than the intake side, complementing the lipolytic effects of AOD-9604 and the anabolic protection of CJC-1295/Ipamorelin. Acts as a cellular exercise mimetic.